Nanjing Pharmaceutical Group Company Limited engages in the distribution of pharmaceuticals, medical devices, and health products in China. It also involved in the wholesale and retail of pharmaceuticals; provision of internet + Chinese medicine pharmacy service platform; and pharmaceutical third-party logistics services. The company was formerly known as NanJing Pharmaceutical Company Limited and change its name to Nanjing Pharmaceutical Group Company Limited in December 2025. Nanjing Pharmaceutical Group Company Limited was founded in 1951 and is based in Nanjing, China.
Frequently asked questions
What sector does NanJing Pharmaceutical Co Ltd (600713) operate in?
NanJing Pharmaceutical Co Ltd belongs to the Healthcare sector and operates in the Drug Manufacturers - General industry.
What is NanJing Pharmaceutical Co Ltd (600713) current stock price?
As of the latest data, NanJing Pharmaceutical Co Ltd stock price is CN¥4.92, with a previous close of CN¥4.94. NanJing Pharmaceutical Co Ltd lost -CN¥0.02 in the last trading session, representing a -0.4% loss.
What is NanJing Pharmaceutical Co Ltd (600713) current market capitalization?
NanJing Pharmaceutical Co Ltd market cap is approximately 6.44 billion.
What is NanJing Pharmaceutical Co Ltd (600713) Earnings Per Share (EPS)?
The trailing EPS is CN¥0.43.
What is NanJing Pharmaceutical Co Ltd (600713) Price-to-Earnings (P/E) ratio?
NanJing Pharmaceutical Co Ltd current P/E ratio is 11.44.
Does NanJing Pharmaceutical Co Ltd (600713) pay dividends?
No. NanJing Pharmaceutical Co Ltd does not pay a dividend.
What is NanJing Pharmaceutical Co Ltd (600713) beta (volatility) score?
NanJing Pharmaceutical Co Ltd has a beta of 0.193, indicating lower volatility than the overall market.
